Atopic dermatitis, the most common form of eczema, affects millions and often comes hand-in-hand with allergies and other ...

We found some great early deals for Amazon’s Summer Beauty Event Amazon’s Summer Beauty Event officially starts Monday, April ...

Explore Alix Earle's skincare line, Reale Actives, crafted with Dr. Kiran Mian, and discover its innovative launch strategy.

Climate change may be making poison ivy more toxic, as the plant performs well under conditions with high carbon dioxide ...

Machine learning models can predict the risk for developing moderate-to-severe persistent asthma and allergic rhinitis in ...

TheFly reported on April 10 that Evercore ISI pointed to media reports suggesting that Sun Pharmaceutical may be nearing a ...

The FDA granted fast track designation to KT-621 for treating patients with moderate to severe eosinophilic asthma, according ...

(RTTNews) - Corvus Pharmaceuticals, Inc. (CRVS) announced positive results from Cohort 4 of its placebo-controlled Phase 1 clinical trial evaluating Soquelitinib, the company's lead ITK inhibitor, in ...

Seborrheic dermatitis may disrupt the skin barrier, potentially exposing patients to other epithelial barrier diseases (EBDs) across various organ systems. A large cohort study found positive ...

In a US study of over 20 million patients, seborrheic dermatitis showed significant associations with multiple epithelial barrier diseases (EBDs), including various skin, gastrointestinal, and ocular ...

Both dosing regimens of amlitelimab were found to significantly improve skin clearance and disease severity. Topline results were announced from a phase 3 trial evaluating amlitelimab for the ...

Panelists discuss how atopic dermatitis involves complex inflammatory and neuronal pathways, with IL-4, IL-13, and IL-31 cytokines driving Th2-mediated inflammation that varies across different racial ...